-
Loading metrics
GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes
- Kunal Zaveri,
- Girish Kulkarni,
- Rathish Nair,
- Govarthanan Shanmugan,
- Shubhada Amol Dharmadhikari,
- R. P. S. Makkar,
- Rahul Jalgaonkar,
- B. D. Chatterjee,
- Krishnaprasad Korukonda,
- GLIMSI Investigator(s) Study Panel
x
- Published: February 6, 2026
- https://doi.org/10.1371/journal.pone.0337107